1. Home
  2. CHNR vs MYNZ Comparison

CHNR vs MYNZ Comparison

Compare CHNR & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHNR
  • MYNZ
  • Stock Information
  • Founded
  • CHNR N/A
  • MYNZ 2021
  • Country
  • CHNR Hong Kong
  • MYNZ Germany
  • Employees
  • CHNR N/A
  • MYNZ N/A
  • Industry
  • CHNR Precious Metals
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHNR Basic Materials
  • MYNZ Health Care
  • Exchange
  • CHNR Nasdaq
  • MYNZ Nasdaq
  • Market Cap
  • CHNR 8.6M
  • MYNZ 9.8M
  • IPO Year
  • CHNR 1995
  • MYNZ 2021
  • Fundamental
  • Price
  • CHNR $0.78
  • MYNZ $0.38
  • Analyst Decision
  • CHNR
  • MYNZ Buy
  • Analyst Count
  • CHNR 0
  • MYNZ 2
  • Target Price
  • CHNR N/A
  • MYNZ $3.00
  • AVG Volume (30 Days)
  • CHNR 722.1K
  • MYNZ 1.4M
  • Earning Date
  • CHNR 05-16-2023
  • MYNZ 08-13-2024
  • Dividend Yield
  • CHNR N/A
  • MYNZ N/A
  • EPS Growth
  • CHNR N/A
  • MYNZ N/A
  • EPS
  • CHNR N/A
  • MYNZ N/A
  • Revenue
  • CHNR N/A
  • MYNZ $895,479.00
  • Revenue This Year
  • CHNR N/A
  • MYNZ $67.40
  • Revenue Next Year
  • CHNR N/A
  • MYNZ $191.13
  • P/E Ratio
  • CHNR N/A
  • MYNZ N/A
  • Revenue Growth
  • CHNR N/A
  • MYNZ 69.00
  • 52 Week Low
  • CHNR $0.61
  • MYNZ $0.32
  • 52 Week High
  • CHNR $8.85
  • MYNZ $4.71
  • Technical
  • Relative Strength Index (RSI)
  • CHNR 48.18
  • MYNZ 41.15
  • Support Level
  • CHNR $0.74
  • MYNZ $0.34
  • Resistance Level
  • CHNR $0.86
  • MYNZ $0.46
  • Average True Range (ATR)
  • CHNR 0.06
  • MYNZ 0.07
  • MACD
  • CHNR 0.01
  • MYNZ 0.01
  • Stochastic Oscillator
  • CHNR 54.61
  • MYNZ 25.10

About CHNR China Natural Resources Inc.

China Natural Resources Inc is an investment holding company. It principally engaged in the exploration and mining and wastewater treatment businesses in the People's Republic of China. The company has two operating segments: (i) Wastewater treatment segment, which consists of sales of assembled equipment, provision of construction service, and participation in PPP projects as an operator (ii) Exploration and mining segment, which consists of the exploration of lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and the trading of copper ores products. It earns the majority of its revenue from the Wastewater treatment segment.

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.

Share on Social Networks: